Abiraterone is a pregnenolone analogue that can effectively and irreversibly inhibit the CYP17 enzyme in the human body. Therefore, it can inhibit the synthesis of androgens from the source and inhibit the growth of androgen-dependent prostate cancer. Abiraterone was approved by the FDA in 2012 for the treatment of metastatic castration-resistant prostate cancer. The monthly cost of medication for each patient in the United States is not pocket friendly. Even with first-class commercial insurance. The Abiraterone cost is very expensive.
Medixo Centre offers Abiraterone at wholesale prices because it understands that affordable options are important. Patients can save a lot of money by taking advantage these discounted prices.
You must log in or register a new account in order to contact the publisher